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ABSTRACT
Cognitive impairment, activities of daily living, and mortality 
among the elderly in rural South Korea: Kangwha Cohort Study
                                                          Cho, Jeong Ae
                                                 Dept. of Public Health
                                                 The Graduate School
                                                 Yonsei University
Purpose: Purpose: The purpose of this study is to examine the effects 
through the various combinations of cognitive impairment and ADL 
disability with mortality due to all-cause, vascular diseases, cancer, and 
senility, in a 14.5-year prospective cohort among community-dwelling 
elderly Koreans. 
Methods: The cohort involved 2,501 participants ages 64 years and older 
starting from July 1994 to December 2008. Chi-squared tests and one-way 
analysis of variance (ANOVA) were performed to compare differences 
between the groups. Cox proportional hazards models were used to 
evaluate the associations among cognitive performance, ADL, and 
mortality.
Results: There were 1,481 deaths during the follow-up. Mortality risks due 
to all-cause, vascular diseases, and senile were significantly associated 
with cognitive impairment and ADL disability. No association was found 
between cancer mortality and cognitive impairment or ADL disability. 
Domain-specific cognitive impairment or task-specific ADL disability was 
diversely related with cause-specific mortality. When cognitive impairment 
- viii -
and ADL disability were combined, the Synergy index increased due to 
interaction. The effects indicated all-cause (HR=2.72), vascular disease 
(HR=3.40), and senility (HR=1.58).
Conclusion: Cognitive impairment and ADL disability are important risk 
factors towards the increase of mortality due to all-cause, vascular 
disease, and senility, but cancer didn’t suggest concrete correlation.  
Domain-specific cognitive function and task-specific ADL predicted the 
mortality risk. Combining cognitive impairment and ADL disability showed a 
higher risk for coexisting variables than for cognitive impairment or ADL 
disability alone.
_____________________________________________________________________________
Key words: Cognitive impairment (MMSE-K), activities of daily living(ADL),  
            all-cause, vascular diseases, senility, mortality
- ix -
ADL activities of daily living
aHR adjusted Hazard Ratio
BMI body mass index
BP blood pressure
CI confidence interval
CVD cardio vascular disease
IADL instrumental activities of daily living
ICD-10 International Classification of Diseases 10th edition
MCI mild cognitive impairment
MMSE-K Mini-Mental State Examination Korean version
HR hazard ratio
RERI the relative excess risk due to interaction 
S synergy index
SPMSQ short potable mental status questionnaire
SD standard deviation
Abbreviations:
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I. INTRODUCTION
     Functional capacity is a key indicator that measures the health status 
and independent living of the older adults. Older adults are under the 
effects of chronic diseases, complications, and may lose their mental and 
physical functions later in their life. Lack of functional capacity may cause 
increase in morbidity (Sands et al., 2002; Strauss et al., 2003; Dodge et 
al., 2005; Fauth et al., 2012; Robertson et al., 2013), mortality (Stuck et 
al., 1999; Ramos et al., 2001; Millán-Caleti et al., 2010; O’Donnell et al., 
2012; Santabárbara et al., 2014), and most likely healthcare costs 
(Alzheimer’s Disease International, 2015).
     According to the reports, while the population of older adults has 
grown 17.4%, older adults with dementia grew 28.5%, and the prevalence 
of dementia increased from 8.4% in 2008 to 9.18% in 2012. The rate of 
the prevalence of dementia indicates 15.5% for severe, 25.7% for 
moderate, 41.4% for mild, and 17.4% for minimal of cognitive impairments 
(Ministry of Health & Welfare 2008 & 2013; Clinical Research center for 
Dementia 2014). Approximately 10-15% of Mild Cognitive Impairment (MCI) 
is converted to dementia every year (Ha et al., 2014). As a result, cost of 
dementia treatment and dependent care expenses enlarged by 87% from 
30.6 billion (Korean won) in 2008 to 57.2 billion in 2013. This cost 
includes the financial contributions of both the central government and the 
local and regional government, excluding personal expenses (National 
Assembly Budget Office, 2014). Furthermore, due to rapid aging of the 
population, the number of dementia patients would presumably double in 
every 20 years (Ministry of Health and Welfare, 2011). According to the 
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diagnoses of Korean National Statistical of the mortality data, around 5,000 
people die from dementia in Korea with the mortality rate of 12 out of one 
hundred thousand people (Statistics Korea, 2015).
     The mini-mental state examination (MMSE) has contributed to 
detecting cognitive impairment with dementia (Magni et al., 1996; 
Fabrigoule et al., 2003; Pezzotti et al., 2008). Several studies have 
publicized the relationship between the cognitive impairment and 
correspondent with higher mortality rate after adjusting the confounding 
variables (Dewey et al., 2001; Jacobs et al., 2011; O’Donnell et al., 2012; 
Park et al., 2014; Santabárbara et al., 2014). Cognitive function domains, 
which are based on MMSE-K, include ‘orientation to time’, ‘orientation to 
place’, ‘registration’, ‘attention and calculation’, ‘recall’, ‘naming and 
repetition’, ‘three-stage command’, ‘copying’, and ‘comprehension’ (Park et 
al., 1990). Cognitive impairment in the community-based studies is 
associated with disabilities of Activities of Daily Living (ADL) (Dodge et al., 
2005; Ishizaki et al., 2006; Ayalon et al., 2008; Park et al., 2014). 
However, whether the cognitive impairment or ADL disability has the 
association with cause-specific mortality after adjusting for confounding 
variables is yet debatable (Altieri. 2002; Nguyen et al., 2003; Anstery et 
al., 2006; Benito-León et al., 2014; Katsoulis et al., 2014; Paddick et al., 
2015).
     ADL disability is calculated based on essential activities of everyday 
(World Health Organization, 2001). Physical ADL modified from Katz index 
includes ‘bathing’, ‘dressing’, ‘toileting’, transferring (‘moving in the bed’; 
and ‘moving around the house’), ‘eating’, and ‘continence’ (Katz et al., 
1976). Physical ADL reflects rudimentary functions for independent living of 
the older adults. ADL disability is often followed by frailty status (Takata et 
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al., 2013), tends to remain substantially until the end of dementia (Ha et 
al., 2014), and predicts mortality in older adults (Matsubayashi et al., 
1999; Ramos et al., 2002; Cesari et al., 2008; Millán-Calenti et al., 2010; 
Nakazawa et al., 2012). Particularly, functional capacity is wheeled by 
cognitive function and ADL; because geriatric studies focus on mental and 
physical health, cognitive impairment and ADL disability can predict 
mortality for older adults. Most functional disability studies have evaluated 
cognitive impairment and ADL disability by a single factor, or have divided 
them into two factors or more (Bassuk et al., 2000; Ishizaki et al., 2006;  
Johnson et al., 2007; Iwashyna et al., 2010; Santabárbara et al., 2015). 
Only a small number of studies show the association between 
domain-specific cognitive impairment with mortality or task-specific ADL 
with mortality for the functional capacity with different indexes. Little is 
known about the relationship between cause-specific mortality and 
functional capacity by subdivisions of cognitive impairment or ADL 
disability. The association with cause-specific mortality in cognitive 
impairment as well as with ADL disability have not been carefully 
examined; however, it is important to investigate possible preventions of 
cognitive impairment and disability. For inclusive understanding of the 
overall effects, the comprehensive interaction should be known between 
full factors of functional capacity and mortality.
     The study has three objectives. First, we wished to clarify the 
association between cognitive impairment with mortality and ADL disability 
with mortality due to all-cause, vascular disease, cancer, and senility. 
Second, we attempted to investigate the association between 
domain-specific cognitive impairments with cause-specific mortality and 
task-specific ADL with cause-specific mortality. Third, we tried to 
- 4 -
summarize the combined effects by of task-specific ADL and cognitive 
impairment status with cause-specific mortality in a 14.5-year prospective 
cohort among community-dwelling elderly Koreans. We expected that 
mortality would be associated with an increased likelihood of cognitive 
impairment and ADL combined than a single individual functional status of 
either cognitive impairment or ADL disability.
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II. OBJECTIVES
     The purpose of this study is to examine the effects through the 
various combinations of cognitive impairment and ADL disability with 
mortality due to all-cause, vascular diseases, cancer, and senility in a 
14.5-year prospective cohort among community-dwelling elderly Koreans. 
1. To assess cognitive impairment, ADL disability and their attributions to 
the cause-specific mortality due to all-cause, vascular diseases, cancer, 
and senility
2. To evaluate the association between task-specific ADL with cause- 
specific mortality and domain-specific cognitive performance with 
cause-specific mortality due to all-cause, vascular diseases, cancer, 
and senility by functional status of each criterion
3. To explore the combined effects of cognitive performance and ADL for 
cause-specific mortality due to all-cause, vascular diseases, cancer, 
and senility
- 6 -
III. MATERIALS AND METHODS
  A. Study participants
     This study used data from the Kangwha Cohort Study (Yi et al., 
2009; Sull et al., 2010). From July to August in 1994, 3,592 (85.2%) of 
4,217 survivors (50 losses to follow-up and 2,105 deaths as of July, 1994) 
of the 6,372 who participated in the first survey in March 1985, 
participated in the second survey. After excluding those with missing 
cognitive function (n=1,068), activities of daily living (n=14), hypertension 
(n=3), or marriage (n=6), a final 2,501 participants (1,059 men, 1,442 
women) were included in the analysis. The Institutional Review Board of 
Human Research of Yonsei University approved the study (approval no. 
4-2007-0182).
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Kangwha Cohort Study
1st  Survey: Mar. 1985 
N=6,372
● Follow up missing n=50
● Death n=2,105
2nd Survey: July-Aug 1994
    N=3,592 (85.2%) of 4,217
Excluded N=1,091
● Missing Cognitive Function n=1,068
● Activity of Daily Living n=14
● Hypertension n=3
● Marriage n=6
Total N=2,501
Men n=1,059
   Women n=1,442
Figure 1. Flow chart describing study participants, Kangwha Cohort Study
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  B. Data collection
     The survey was conducted in July 1994. Trained researchers 
interviewed participants using a structured questionnaire to obtain 
demographic characteristics and health related information, including age at 
entry, gender, education, occupation, tobacco and alcohol consumption, 
chronic disease history, marital status, cognitive function and activities of 
daily living (Basic or Physical ADL) at the time of survey, and measured 
their blood pressure, height, and weight. More details of the data collection 
can be found elsewhere (Yi et al., 2009; Yi et al., 2010).
  C. Cognitive testing
     Cognitive function was assessed through a survey in 1994 using the 
Korean Version of the Mini-Mental State Examination (MMSE-K) (Park and 
Kwon, 1990). The MMSE-K includes 7 domains (or 9 domains considering 
sub-domains in language) that measure orientation to time (5 points), 
orientation to place (5 points), registration (3 points), attention and 
calculation (5 points), recall (3 points), language (7 points; Naming and 
repetition [3 points], three-stage command [3 points], copying [1 point]), 
and comprehension and judgement (2 points). One point was added to 
scores of orientation to time, two to scores of attention and calculation, 
and one to scores of a language function (repetition) to non-educated 
individuals who did not make full score at each corresponding item, for 
the adjustment purpose due to a low educational status of Korean elderly 
(Park and Kwon, 1990). The MMSE-K ranges from 0 to 30-point, with a 
higher score indicating better cognitive function (O'Donnell et al., 2012; 
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Park and Kwon, 1990) Cognitive performance was categorized into 4 
groups based on the median (no impairment [reference, 23-30 point], mild 
[19-22], moderate [14-18], severe [0-13]), 20 percentiles, and 5 percentiles 
of MMSE-K score, and into 3 groups (combining no and mild impairment, 
moderate, and severe). For a sensitivity analysis, it was also categorized 
into 3 groups (MMSE-K score; 25-30, 21-24, 0-20) suggested by the 
developers of MMSE-K (Park and Kwon, 1990), and 4 groups (23-30, 
18-22, 13-17, 0-12) based on -2SD (standard deviation), -1SD, and mean 
scores. Cut-off points were generally lower in this study than in other 
studies that use MMSE or MMSE-K, since only 41% of participants had 
formal education.
  D. Measures of activities of daily living
     Basic ADL disability was evaluated by the following seven criteria 
modified from previous research (Katz et al., 1963): ‘bathing’, ‘dressing’, 
‘toileting’, ‘moving in the bed’, ‘moving around the house’, ‘eating’, and 
‘continence’. They rated the task dependence when performing each 
activity except ‘continence’ as by self with ease (0), by self but with 
difficulty (1), with partial assistance from others (2), and unable to perform 
the activity without help (3). For the performance of the ‘continence’, they 
were asked to answer one of the four categories; controls urination and 
bowel movement completely by self (0), has occasional accidents (1), has 
frequent accidents (2), is incontinent or others help control (3). The ADL 
test ranges from 0 to 21, with a higher score indicating poorer 
performance. Participants were categorized into 3 groups; independence 
[0], partial dependence [1-2 point], dependence [3-21 point]).
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  E. Follow-up and outcome ascertainment
     Deaths among subjects from 1 July 1994 through 31 December 2008 
were confirmed by the death records held at the National Statistical Office 
(Yi et al., 2009). Follow-up was performed through the record linkage at 
the national level and was complete. The main outcomes for this study 
were death from all-causes, cancers (C00-D58), vascular diseases 
(I00-I99), and senility (R54) as defined by the International Classification of 
Disease, Tenth Revision (ICD-10). 
  F. Statistical analysis
     Chi-squared tests and one-way analysis of variance (ANOVA) were 
performed to compare differences between the groups. Cox proportional 
hazards models were used to evaluate the association between cognitive 
performance with mortality and ADL with mortality. Analyses were adjusted 
for the following covariance where applicable; age at entry (continuous), 
gender, known hypertension (based on measured BP ≥140/90 mmHg or 
self-reported regular medication on hypertension; yes, no), smoking status 
(non-smoker, former smoker, current smoker), alcohol drinking status 
[(non-drinker, former drinker, current drinker) at least from March 1985], 
occupation (agriculture, other), education (none, elementary school, middle 
school or above), marital status (living with, without spouse), self-reported 
health (good or fair, poor), and body mass index (BMI, kg/㎡; <18.5, 
18.5-20.9, 21.0-24.9, 25.0-27.4, ≥27.5).
     A stratified analysis was performed according to the statuses of 
cognitive impairment (no or mild, moderate, and severe) or the levels of 
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ADL disability (independence, partial dependence, and dependence) to 
examine whether to confirm the association between cognitive performance 
and ADL each with cause-specific mortality. Combined effect of cognitive 
performance and ADL was also assessed via constructing a 9-level 
variable that combined 3 statuses of cognitive impairment with 3 levels of 
ADL disability. Additionally, analyses of the participants with follow-up until 
2000, and analyses of survivors as from January 1, 2001 with follow-up 
until 2008, were done to evaluate whether the association differs by 
follow-up period. These various analyses served as a sensitivity analysis.
     Two-sided p-values were calculated and the statistical significance 
level was set at 0.05. All statistical analyses were performed using SAS 
version 9.4 (SAS Institute, Cary, NC, USA).
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IV. RESULTS
  A. General characteristics of the study participants
    The total follow-up person-years numbered 28,225. During the 14.5 
years of follow-up, all-cause mortality of 1,481 participants died of vascular 
diseases (345), cancer (232), and senility (428). The average (SD) age of 
the participants was 72.6 years at enrollment. Age, hypertension, poor 
self-rated health condition (p=0.2175), and ADL dependency increased 
across the four categories of cognitive impairment statuses; no, mild, 
moderate, severe. The proportion of women was higher in groups of 
moderate-to-severe cognitive impairment than that of no-or-mild impairment 
(Table 1).
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Table 1. Baseline characteristics of the study participants by cognitive impairment in Kangwha Cohort Study during 1994-2008
Cognitive impairment status
Total (N=2,501) No (n=1,224) Mild (n=686) Moderate (n=441) Severe (n=150) p-value
mean±SD mean±SD mean±SD mean±SD mean±SD
Age, year 72.6±6.0 71.1±5.1 73.0±5.7 75.0±6.7 76.3±6.8 <0.0001
BMI (kg/m²) 22.0±3.4 22.1±3.5 22.0±3.3 22.3±15.9 21.2±3.6 0.4455
N (%) N (%) N (%) N (%) N (%)
Gender <0.0001
Men 1,059(42.3) 675(55.1) 240(35.0) 102(23.1) 42(28.0)
Women 1,442(57.7) 549(44.9) 446(65.0) 339(76.9) 108(72.0)
Smoking habits <0.0001
Non smoker 1,427(57.0) 635(51.9) 409(59.6) 288(65.3) 93(62.0)
Former smoker 248( 9.9) 148(12.1) 49( 7.1) 34( 7.7) 17(11.3)
Current smoker 828(33.1) 441(36.0) 228(33.2) 119(27.0) 40(26.7)
Alcohol drinking status <0.0001
Non drinker 1,606(64.2) 696(56.9) 469(68.4) 334(75.7) 107(71.7)
Former drinker 151( 6.0) 86( 7.0) 36( 5.3) 24( 5.4) 5( 3.3)
Current drinker 744(29.8) 442(36.1) 181(26.4) 83(18.8) 38(25.3)
Hypertension 0.0004
No 1,312(52.5) 693(56.6) 341(49.7) 212(48.1) 66(44.0)
Yes 1,189(47.5) 531(43.4) 345(50.3) 229(51.9) 84(55.0)
Self-rated Health 0.2175
Poor 1,008(40.3) 469(38.3) 285(41.5) 187(42.4) 67(44.7)
Good or fair 1,493(59.7) 755(61.7) 401(58.5) 254(57.6) 83(55.3)
BMI categories (kg/m2) 0.0007
<18.5 367(14.7) 163(13.3) 87(12.7) 77(17.5) 40(27.7)
18.5-20.9 681(27.2) 310(25.3) 200(29.2) 130(29.5) 41(27.3)
21-24.9 1,044(41.7) 539(44.0) 293(42.7) 166(37.6) 46(30.7)
25-27.4 264(10.6) 138(11.3) 69(10.1) 44(10.0) 13( 8.7)
≥27.5 145( 5.8) 74( 6.1) 37( 5.4) 24( 5.4) 10( 6.7)
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-Table continued-
Cognitive impairment status
Total (N=2,501) No (n=1,224) Mild (n=686) Moderate (n=441) Severe (n=150) p-value
Education <0.0001
None 1,474(59.0) 607(49.6) 460(67.1) 315(71.4) 92(61.3)
Elementary school or below 922(36.9) 535(43.7) 210(30.6) 120(27.2) 57(38.0)
Middle school or above 105( 4.2) 82( 6.7) 16( 2.3) 6( 1.4) 1( 0.7)
Occupation 0.8486
Non-agriculture 2,099(83.9) 1,019(83.2) 579(84.4) 372(84.3) 128(84.3)
Agriculture 404(16.1) 205(16.8) 107(15.6) 69(15.7) 22(14.7)
Marital status <0.0001
Living with spouse 1,485(59.4) 847(69.2) 392(57.1) 181(41.0) 65(43.3)
Living without spouse 1,016(40.6) 377(30.8) 294(42.9) 260(59.0) 85(56.7)
ADL <0.0001
  Independence 1,737(69.4) 921(75.3) 456(66.5) 276(62.6) 84(56.0)
  Partial dependence 432(17.3) 206(16.8) 124(18.1) 78(17.7) 24(16.0)
  Dependence 332(13.3) 97( 7.9) 106(15.4) 87(19.7) 42(28.0)
Values are presented as mean±SD or number(%); BMI, body mass index; ADL, Activity of Daily Living; Cognitive impairment was 
classified by MMSE-K scores. MMSE-K, Korean version of the Mini-Mental State examination. 
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B. Cause-specific mortality and cognitive impairment 
  1. Cause-specific mortality with cognitive impairment 
     Table 2 showed the association with the hazard ratios (HRs) for 
cause-specific mortality by cognitive impairment after adjusting for age and 
gender (Model 1). Model 2 was adjusted for age, gender, education, 
occupation, marriage, smoker (former, current), drinker (former, current), 
BMI (<18.5; 18.5-20.9; 25.0-27.4; ≥27.5), self-rated health, hypertension, 
ADL disability (partial dependence and dependence), and cognitive 
impairment (moderate and severe). Model 3 comprised ADL (partial 
dependence and dependence) into Model 2. Regarding the cognitive 
status, mortality risks due to all-cause and senility increased significantly 
with a dose-response relationship in all Models. In contrast, cancer 
mortality was not associated with cognitive impairment status, and vascular 
disease mortality was the only risk increased in severe cognitive 
impairment status in Model 1.
     The total follow-up per 100,000 person-years was 28,225 (vascular 
disease mortality 6,416; senile mortality 9,984; cancer mortality 3,335).
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Table 2. Hazard ratios (95% CI) for cause-specific mortality with cognitive impairment status
Cognitive status
No. of 
deaths
total PY
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
All-cause mortality 1,481 2,501 28,225
No impairment 663 1,224 5,081 1.00 1.00 1.00
Mild impairment 404 686 5,777 1.13(0.99-1.28) 0.0728 1.09(0.96-1.24) 0.1842 1.07(0.94-1.21) 0.3202
Moderate impairment 295 441 7,196 1.29(1.11-1.49) 0.0008 1.21(1.05-1.41) 0.0112 1.21(1.04-1.40) 0.0146
Severe impairment 119 150 10,171 1.79(1.46-2.19) <0.0001 1.66(1.35-2.04) <0.0001 1.61(1.31-1.98) <0.0001
Vascular diseases mortality 345 2,501 6,416
No impairment 165 1,224 1,265 1.00 1.00 1.00
Mild impairment 82 686 1,173 0.90(0.69-1.19) 0.4654 0.87(0.66-1.14) 0.3064 0.83(0.63-1.09) 0.1725
Moderate impairment 72 441 1,756 1.26(0.94-1.70) 0.1226 1.22(0.91-1.65) 0.1899 1.19(0.91-1.65) 0.2679
Severe impairment 26 150 2,222 1.60(1.04-2.46) 0.0313 1.51(0.97-2.33) 0.0672 1.37(0.88-2.13) 0.1597
Senile mortality 428 2,501 9,984
No impairment 132 1,224 1,012 1.00 1.00 1.00
Mild impairment 129 686 1,845 1.55(1.20-1.98) 0.0006 1.45(1.13-1.87) 0.0039 1.42(1.10-1.83) 0.0069
Moderate impairment 117 441 2,854 1.81(1.38-2.37) <0.0001 1.61(1.22-2.12) 0.0008 1.58(1.20-2.09) 0.0012
Severe impairment 50 150 4,274 2.53(1.79-3.59) <0.0001 2.32(1.63-3.31) <0.0001 2.23(1.57-3.19) <0.0001
Cancer mortality 232 2,501 3,335
No impairment 138 1,224 1,058 1.00 1.00 1.00 
Mild impairment 56 686 801 1.00(0.73-1.37) 0.9794 0.99(0.72-1.37) 0.9706 0.99(0.72-1.37) 0.9530
Moderate impairment 29 441 707 1.05(0.69-1.60) 0.8097 1.06(0.69-1.61) 0.8012 1.05(0.69-1.60) 0.8238
Severe impairment 9 150 769 1.15(0.58-2.27) 0.6960 1.11(0.56-2.22) 0.7599 1.10(0.55-2.19) 0.7966
HR (95% CI), Hazard Ratios 95% confidence intervals
Model 1: adjusted for age and gender 
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and ADL (partial dependence, dependence)
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  2. Distribution of domain-specific cognitive impairment 
     Table 3 summarized the prevalence of domain-specific cognitive 
impairment by cognitive impairment status. Most domains were increased 
in prevalence of cognitive impairment across all status.  
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Table 3. Distribution of domain-specific cognitive impairment at baseline by cognitive impairment status in Kangwha Cohort Study
Domain-specific 
  cognitive impairment
Cognitive impairment status
Total (N=2,501) No (n=1,224) Mild (n=686) Moderate (n=441) Severe (n=150) p-value
Orientation to time <0.0001
  No or mild impairment 1,926(77.0) 1,197(97.8) 536(78.1) 160(36.3) 33(22.0)
  Impairment 575(23.0) 27( 2.2) 150(21.9) 281(63.7) 117(78.0)
Orientation to place <0.0001
  No or mild impairment 2,151(86.0) 1,207(98.6) 615(89.7) 282(64.0) 47(31.3)
  Impairment 350(14.0) 17( 1.4) 71(10.3) 159(36.0) 103(68.7)
Registration <0.0001
  No or mild impairment 2,214(88.5) 1,198(97.9) 637(92.9) 339(76.7) 40(27.0)
  Impairment 287(11.5) 26( 2.1) 49( 7.1) 102(23.1) 110(73.0)
Attention and Calculation <0.0001
  No or mild impairment 1,142(45.7) 912(74.5) 177(25.8) 48(10.9) 5( 3.3)
  Impairment 1,359(54.3) 312(25.5) 509(74.2) 393(89.1) 145(96.7)
Recall <0.0001
  No or mild impairment 1,227(49.1) 832(68.0) 286(41.7) 101(22.9) 8( 5.3)
  Impairment 1,274(50.9) 392(32.0) 400(58.3) 340(77.1) 142(94.7)
Naming and Repetition <0.0001
  No or mild impairment 2,398(95.9) 1,208(98.7) 663(96.6) 417(94.6) 110(73.3)
  Impairment 104( 4.1) 16( 1.3) 23( 3.4) 24( 5.4) 40(26.7)
Three-stage Command <0.0001
  No or mild impairment 2,313(92.5) 1,208(98.7) 642(93.6) 380(86.2) 83(55.3)
  Impairment 188( 7.5) 16( 1.3) 44( 6.4) 61(13.8) 67(44.7)
Copying <0.0001
  No or mild impairment 738(29.5) 586(47.9) 107(15.6) 35( 7.9) 10( 6.7)
  Impairment 1,763(70.5) 638(52.1) 579(84.4) 406(92.1) 140(93.3)
Comprehension <0.0001
  No or mild impairment 1,890(75.6) 1,127(92.1) 508(74.0) 219(49.7) 36(24.0)
  Impairment 611(24.4) 97( 7.9) 178(26.0) 222(50.3) 114(76.0)
Values denote numbers with percentages (%) in parentheses; Cognitive impairment was classified by MMSE-K scores, Korean 
version of the Mini-Mental State Examination.
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  3. Cause-specific mortality with domain-specific cognitive impairment 
     Table 4 showed that the all-cause mortality risk was strongly 
associated with domain-specific cognitive impairment status except ‘naming 
and repetition’ in age and gender adjusted to Model 1. In the Model 2, 
the risks were constantly significant with ‘orientation to time’, ‘orientation to 
place’, ‘three-stage command’, ‘copying’, and ‘comprehension’.
     Table 5 indicated that two domains ('orientation to place’ and 
‘three-stage command’) were significantly associated with the vascular 
disease mortality in model 1, and only 'orientation to place' domain 
reached the risk in Model 2 and 3.
     The domain-specific cognitive impairments for senile mortality were 
significantly associated with most domains, except 'orientation to place' and 
‘naming and repetition’. Especially, 'copying' domain (HR=1.90; 95% CI, 
1.41-2.55) presented higher risk score than any other cause-specific 
cognitive impairment domains in model 3 (Table 6).
     
     Cancer mortality was not associated with any cognitive impairment 
domain (Appendix table 4).
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Table 4. Hazard ratios (95% CI) for all-cause mortality with domain-specific cognitive impairment
Domain-specific Cognitive impairment 
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
All-cause mortality (event=1,481)
  Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.23(1.09-1.39) 0.0007 1.17(1.04-1.33) 0.0104 1.16(1.03-1.32) 0.0167
  Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 1.27(1.10-1.47) 0.0012 1.20(1.04-1.39) 0.0131 1.22(1.05-1.41) 0.0087
  Registration No or mild 1.00 1.00 1.00
Moderate & severe 1.25(1.07-1.45) 0.0041 1.14(0.98-1.33) 0.0847 1.14(0.98-1.33) 0.1029
  Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 1.12(1.00-1.24) 0.0469 1.11(0.99-1.24) 0.0650 1.09(0.98-1.22) 0.1072
  Recall No or mild 1.00 1.00 1.00
Moderate & severe 1.11(1.00-1.24) 0.0433 1.11(1.00-1.24) 0.0467 1.10(0.99-1.22) 0.0912
  Naming & Repetition No or mild 1.00 1.00 1.00
Moderate & severe 1.15(0.89-1.47) 0.2842 1.13(0.88-1.45) 0.3435 1.13(0.88-1.46) 0.3325
  Three-stage Command No or mild 1.00 1.00 1.00
Moderate & severe 1.25(1.04-1.50) 0.0173 1.20(1.00-1.45) 0.0470 1.18(0.99-1.42) 0.0713
  Copying No or mild 1.00 1.00 1.00
Moderate & severe 1.28(1.13-1.44) <0.0001 1.23(1.08-1.40) 0.0016 1.22(1.07-1.39) 0.0030
  Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 1.27(1.13-1.43) <00001 1.23(1.09-1.39) 0.0008 1.22(1.08-1.38) 0.0011
HR (95% CI), Hazard Ratios 95% confidence intervals
Model 1: adjusted for age and gender 
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and ADL (partial dependence, dependence)
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Table 5. Hazard ratios (95% CI) for vascular disease mortality with domain-specific cognitive impairment 
Domain-specific Cognitive impairment 
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Vascular disease mortality (event n=345)
  Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.20(0.93-1.55) 0.1517 1.23(0.95-1.58) 0.1182 1.20(0.93-1.55) 0.1665
  Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 1.43(1.07-1.91) 0.0153 1.39(1.04-1.86) 0.0265 1.40(1.04-1.87) 0.0244
  Registration No or mild 1.00 1.00 1.00
Moderate & severe 1.25(0.91-1.71) 0.1734 1.15(0.84-1.59) 0.3913 1.13(0.82-1.56) 0.4541
  Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 0.91(0.73-1.13) 0.3907 0.86(0.69-1.08) 0.2024 0.84(0.67-1.05) 0.1254
  Recall No or mild 1.00 1.00 1.00
Moderate & severe 1.03(0.83-1.28) 0.7876 1.05(0.85-1.31) 0.6372 1.03(0.83-1.28) 0.7995
  Naming & Repetition No or mild 1.00 1.00 1.00
Moderate & severe 0.89(0.50-1.59) 0.6978 0.89(0.50-1.59) 0.6886 0.86(0.48-1.54) 0.6159
  Three-stage Command No or mild 1.00 1.00 1.00
Moderate & severe 1.49(1.05-2.12) 0.0258 1.41(0.99-2.00) 0.0581 1.33(0.93-1.89) 0.1138
  Copying No or mild 1.00 1.00 1.00
Moderate & severe 1.09(0.85-1.40) 0.4902 1.10(0.84-1.43) 0.4973 1.05(0.80-1.37) 0.7313
  Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 1.24(0.97-1.58) 0.0941 1.22(0.95-1.57) 0.1191 1.21(0.94-1.55) 0.1387
HR (95% CI), Hazard Ratios 95% confidence intervals
Model 1: adjusted for age and gender 
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and ADL (partial dependence, dependence)
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Table 6. Hazard ratios (95% CI) for senile mortality with domain-specific cognitive impairment 
Domain-specific Cognitive impairment 
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Senile mortality (n=428)
  Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.31(1.06-1.63) 0.0116 1.18(0.95-1.47) 0.1279 1.15(0.92-1.43) 0.2112
  Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 1.15(0.89-1.49) 0.2734 1.10(0.85-1.42) 0.4771 1.12(0.87-1.45) 0.3907
  Registration No or mild 1.00 1.00 1.00
Moderate & severe 1.43(1.11-1.83) 0.0055 1.31(1.02-1.69) 0.0360 1.28(0.99-1.66) 0.0567
  Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 1.66(1.34-2.06) <.0001 1.65(1.32-2.05) <.0001 1.62(1.30-2.02) <.0001
  Recall No or mild 1.00 1.00 1.00
Moderate & severe 1.34(1.09-1.64) 0.0054 1.26(1.02-1.55) 0.0318 1.25(1.01-1.54) 0.0396
  Naming & Repetition No or mild 1.00 1.00 1.00
Moderate & severe 1.18(0.73-1.89) 0.5041 1.29(0.80-2.10) 0.2966 1.30(0.80-2.11) 0.2889
  Three-stage Command No or mild 1.00 1.00 1.00
Moderate & severe 1.37(1.01-1.87) 0.0453 1.42(1.04-1.93) 0.0286 1.39(1.02-1.90) 0.0367
  Copying No or mild 1.00 1.00 1.00
Moderate & severe 2.15(1.62-2.85) <.0001 1.93(1.43-2.59) <.0001 1.90(1.41-2.55) <.0001
  Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 1.50(1.22-1.85) 0.0002 1.40(1.13-1.73) 0.0019 1.38(1.12-1.71) 0.0027
HR (95% CI), Hazard Ratios 95% confidence intervals
Model 1: adjusted for age and gender 
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and ADL (partial dependence, dependence)
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C. Cause-specific mortality and ADL disability 
  1. Cause-specific mortality with ADL disability
  
     Concerning ADL levels, mortality risks due to all-cause, vascular 
diseases, and senility were significantly associated with ADL dependency 
in Table 7. In contrast, no association was found between cancer mortality 
and ADL disability.
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Table 7. Hazard ratios (95% CI) for cause-specific mortality with ADL disability levels 
ADL levels
No. of 
deaths
total PY
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
All-cause mortality 1,481 2,501 21,346
Independence 960 1,737 5,191 1.00 1.00 1.00
Partial dependence 271 432 6,417 1.17(1.02-1.34) 0.0224 1.12(0.98-1.29) 0.1043 1.14(0.99-1.31) 0.0686
Dependence 250 332 9,738 1.69(1.46-1.94) <.0001 1.48(1.28-1.71) <.0001 1.45(1.25-1.68) <.0001
Vascular diseases mortality 345 2,501 5,354
Independence 218 1,737 1,179 1.00 1.00 1.00 
Partial dependence 52 432 1,227 1.01(0.75-1.38) 0.9285 0.88(0.65-1.20) 0.4330 0.89(0.66-1.22) 0.4737
Dependence 75 332 2,949 2.36(1.80-3.09) <.0001 1.90(1.44-2.52) <0.0001 1.91(1.44-2.53) <0.0001
Senile mortality 428 2,501 7,625
Independence 257 1,737 1,498 1.00 1.00 1.00 
Partial dependence 81 432 2,170 1.06(0.82-1.37) 0.6587 1.06(0.82-1.37) 0.6597 1.08(0.84-1.40) 0.5392
Dependence 90 332 3,957 1.66(1.30-2.13) <.0001 1.52(1.18-1.95) 0.0013 1.45(1.12-1.86) 0.0046
Cancer mortality 232 2,501 2,486
Independence 181 1,737 979 1.00 1.00 1.00 
Partial dependence 31 432 731 0.89(0.61-1.31) 0.5576 0.87(0.59-1.28) 0.4768 0.87(0.59-1.29) 0.4872
Dependence 20 332 776 1.02(0.64-1.63) 0.9280 1.03(0.64-1.67) 0.8983 1.03(0.64-1.67) 0.9069
HR (95% CI), Hazard Ratios 95% confidence intervals; 
Model 1: adjusted for age and gender
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension 
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and cognitive impairment (mild, moderate, severe)
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2. Distribution of task-specific ADL 
     Table 8 described the prevalence of task-specific ADL by cognitive 
impairment status. Prevalence of most tasks increased across growing 
severity in cognitive impairment. 'Bathing' task marked higher in prevalence 
at severe status than other tasks.
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Table 8. Distribution of task-specific ADL at baseline by cognitive impairment status in Kangwha Cohort Study
Domain-specific ADL
Cognitive impairment status
Total (N=2,501) No (n=1,224) Mild (n=686) Moderate (n=441) Severe (n=150) p-value
Bathing <0.0001
  Independence 2,131(85.2) 1,115(91.1) 577(84.1) 336(76.2) 103(68.7)
  Dependence 370(14.8) 109( 8.9) 109(15.9) 105(23.8) 47(31.3)
Dressing <0.0001
  Independence 2,279(91.1) 1,163(95.0) 624(91.0) 376(85.3) 116(77.3)
  Dependence 222( 8.9) 61( 5.0) 62( 9.0) 65(14.7) 34(22.7)
Toileting <0.0001
  Independence 2,327(93.0) 1,178(96.2) 641(93.4) 388(88.0) 121(80.0)
  Dependence 174( 7.0) 46( 3.8) 45( 6.6) 53(12.0) 31(20.4)
Moving in Bed 0.0007
  Independence 1,955(78.2) 999(81.6) 515(75.1) 327(74.2) 115(76.0)
  Dependence 546(21.8) 225(18.4) 171(24.9) 114(25.8) 37(24.0)
Moving around the house <0.0001
  Independence 1,909(76.3) 983(80.3) 504(73.5) 315(71.4) 108(71.3)
  Dependence 592(23.7) 241(19.7) 182(26.5) 126(28.6) 45(28.7)
Eating <0.0001
  Independence 2,413(96.5) 1,202(98.2) 664(96.8) 413(93.6) 135(89.3)
  Dependence 88( 3.5) 22( 1.8) 22( 3.2) 28( 6.4) 17(10.7)
Continence <0.0001
  Independence 2,409(96.3) 1,205(98.4) 666(97.1) 409(92.7) 130(86.0)
  Dependence 92( 3.7) 19( 1.6) 20( 2.9) 32( 7.3) 22(14.5)
Values denote numbers with percentages (%) in parentheses; ADL, Activity of Daily Living; 
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   3. Cause-specific mortality with task-specific ADL 
     Table 9 showed that mortality due to all-cause risk was associated in 
robust relationship with full task-specific ADL in all Models. ‘Eating’ task 
(HR=2.16 in Model 1; HR=1.78 in Model 2; HR=1.68 in Model 3) had 
higher hazard ratio than any others. 
     The task-specific ADL for mortality due to vascular disease was 
found to be strongly associated with Model 1, 2 and 3, except ‘moving in 
bed’ task in Model 2 and Model 3. ‘Eating’ task (HR=3.57 in Model 1; 
HR=2.76 in Model 2; HR=2.67 in Model 3) marked the highest hazard 
ratio among other tasks whereas ‘moving in bed’ was not significant in 
Model 2 and 3 (Table 10).
     Table 11 designated that HR for the mortality due to senile was 
significantly associated with three tasks ('bathing', ‘dressing’, and ‘eating’), 
otherwise, ‘toileting’ task was significantly associated in Model 1 and 2, 
however ‘toileting’ task was not in Model 3. 'Moving in bed' and 
'continence' were not related with senile mortality.
     No relationship was found between Cancer mortality and task-specific 
ADL (Appendix table 5).
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Table 9. Hazard ratios (95% CI) for All-cause mortality with task-specific ADL
Task-specific ADL 
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
All-cause mortality (n=1,481)
  Bathing Independence 1.00 1.00 1.00
Dependence 1.76(1.54-2.01) <.0001 1.55(1.35-1.77) <.0001 1.50(1.31-1.73) <.0001
  Dressing Independence 1.00 1.00
Dependence 1.83(1.55-2.14) <.0001 1.59(1.35-1.87) <.0001 1.55(1.31-1.82) <.0001
  Toileting Independence 1.00 1.00
Dependence 1.68(1.41-2.01) <.0001 1.54(1.29-1.84) <.0001 1.47(1.22-1.76) <.0001
  Moving in Bed Independence 1.00 1.00
Dependence 1.27(1.13-1.44) <.0001 1.19(1.05-1.34) 0.0065 1.21(1.07-1.37) 0.0022
  Moving around the house Independence 1.00 1.00
Dependence 1.30(1.16-1.46) <.0001 1.21(1.07-1.36) 0.0019 1.22(1.09-1.38) 0.0010
  Eating Independence 1.00 1.00
Dependence 2.13(1.68-2.69) <.0001 1.78(1.40-2.26) <.0001 1.68(1.32-2.14) <.0001
  Continence Independence 1.00 1.00
Dependence 1.58(1.23-2.02) 0.0003 1.41(1.10-1.81) 0.0066 1.33(1.04-1.71) 0.0239
HR (95% CI), Hazard Ratios 95% confidence intervals; 
Model 1: adjusted for age and gender
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension 
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and cognitive impairment (mild, moderate, severe)
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Table 10. Hazard ratios (95% CI) for Vascular disease mortality with task-specific ADL
Task-specific ADL
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Vascular disease mortality (n=345)
  Bathing Independence 1.00 1.00 1.00
Dependence 2.46(1.91-3.18) <.0001 2.01(1.55-2.61) <.0001 1.96(1.51-2.56) <.0001
  Dressing Independence 1.00 1.00
Dependence 2.81(2.09-3.76) <.0001 2.31(1.71-3.13) <.0001 2.28(1.68-3.10) <.0001
  Toileting Independence 1.00 1.00
Dependence 2.65(1.92-3.65) <.0001 2.31(1.66-3.20) <.0001 2.25(1.61-3.14) <.0001
  Moving in Bed Independence 1.00 1.00
Dependence 1.37(1.07-1.75) 0.0123 1.16(0.90-1.50) 0.2420 1.20(0.93-1.55) 0.1563
  Moving around the house Independence 1.00 1.00
Dependence 1.50(1.18-1.89) 0.0008 1.30(1.02-1.66) 0.0324 1.33(1.05-1.70) 0.0207
  Eating Independence 1.00 1.00
Dependence 3.57(2.38-5.35) <.0001 2.76(1.82-4.19) <.0001 2.67(1.75-4.06) <.0001
  Continence Independence 1.00 1.00
Dependence 2.07(1.31-3.27) 0.0018 1.69(1.07-2.69) 0.0253 1.62(1.01-2.58) 0.0434
HR (95% CI), Hazard Ratios 95% confidence intervals; 
Model 1: adjusted for age and gender
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension 
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and cognitive impairment (mild, moderate, severe)
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Table 11. Hazard ratios (95% CI) for Senile mortality with task-specific ADL
Task-specific ADL
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Senile mortality (n=428)
  Bathing Independence 1.00 1.00 1.00
Dependence 1.73(1.37-2.18) <.0001 1.58(1.25-2.00) 0.0001 1.51(1.19-1.91) 0.0007
  Dressing Independence 1.00 1.00 1.00
Dependence 1.72(1.31-2.27) <.0001 1.58(1.19-2.09) 0.0013 1.49(1.13-1.97) 0.0052
  Toileting Independence 1.00 1.00 1.00
Dependence 1.39(1.02-1.90) 0.0358 1.37(1.00-1.88) 0.0498 1.23(0.90-1.70) 0.1942
  Moving in Bed Independence 1.00 1.00 1.00
Dependence 1.19(0.96-1.48) 0.1085 1.16(0.93-1.45) 0.1962 1.20(0.96-1.51) 0.1044
  Moving around the house Independence 1.00 1.00 1.00
Dependence 1.27(1.03-1.56) 0.0278 1.22(0.98-1.51) 0.0718 1.24(1.00-1.53) 0.0523
  Eating Independence 1.00 1.00 1.00
Dependence 2.22(1.50-3.29) <.0001 1.90(1.27-2.85) 0.0019 1.71(1.14-2.57) 0.0102
  Continence Independence 1.00 1.00 1.00
Dependence 1.46(0.97-2.20) 0.0722 1.38(0.91-2.09) 0.1297 1.24(0.81-1.88) 0.3230
HR (95% CI), Hazard Ratios 95% confidence intervals; 
Model 1: adjusted for age and gender
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
                     BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension 
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and cognitive impairment (mild, moderate, severe)
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D. Association of cause-specific mortality by cognitive impairment
   and ADL disability level
  1. ADL disability level for cause-specific mortality by cognitive        
     impairment status
     Table 12 showed the adjusted Hazard Ratios (aHR) for 
cause-specific mortality by cognitive impairment status and ADL levels. The 
aHR for mortality due to all-cause, vascular disease, and senile 
significantly increased along with moderate to severe cognitive impairment. 
Mortality due to all-cause presented association even in partial dependency 
and dependency in ADL. No significant difference was observed in cancer 
mortality. 
     In moderate cognitive impairment, all-cause mortality risk increased 
with partial dependency (HR=1.44) and dependency (HR=1.98), and severe 
cognitive impairment risk increased with partial dependency (HR=2.37) and 
dependency (HR=2.08).
     In moderate cognitive impairment, vascular disease mortality risk 
increased with dependency (HR=2.16), and severe cognitive impairment 
risk increased with partial dependency (HR=3.70 in borderline p=0.0581) 
and dependency in ADL (HR=4.53).
     In moderate cognitive impairment, senile mortality risk increased with 
dependency in ADL (HR=1.98), and severe cognitive impairment risk 
increased with partial dependency in ADL (HR=3.78). No significant 
difference was observed in cancer mortality.
- 32 -
Table 12. ADL levels for Cause-specific mortality by cognitive impairment status
ADL levels
Cognitive impairment
No or Mild* (n=686)　 Moderate* (n=441) Severe* (n=150)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
All-cause mortality　           (event) 404 295 119
Independence 1.00 1.00 1.00
Partial dependence 1.08(0.83-1.40) 0.5856 1.44(1.05-1.97) 0.0246 2.37(1.32-4.25) 0.0040
Dependence 1.17(0.89-1.54) 0.2604 1.98(1.47-2.65) <.0001 2.08(1.26-3.45) 0.0043
Vascular disease mortality      (event) 82 72 26
Independence 1.00 1.00 1.00
Partial dependence 0.71(0.36-1.37) 0.3040 1.32(0.70-2.51) 0.3897 3.70(0.96-14.33) 0.0581
Dependence 1.43(0.82-2.47) 0.2062 2.16(1.20-3.89) 0.0104 4.53(1.48-13.85) 0.0081
Senile mortality                (event) 129 117 50
Independence 1.00 1.00 1.00
Partial dependence 0.87(0.54-1.40) 0.5653 1.46(0.88-2.43) 0.1467 3.78(1.53-9.36) 0.0041
Dependence 1.26(0.79-2.01) 0.3236 1.98(1.23-3.18) 0.0051 2.21(0.96-5.08) 0.0629
Cancer mortality               (event) 56 29 9
Independence 1.00 1.00 1.00
Partial dependence 1.13(0.56-2.25) 0.7379 0.24(0.03-1.81) 0.1664 - -
Dependence 0.99(0.40-2.45) 0.9869 1.25(0.44-3.51) 0.6780 5.22(0.20-135.95) 0.3208
ADL, Activity of daily living; HR (95% CI), Hazard Ratios 95% confidence intervals; 
*Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
             BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
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  2. Task-specific ADL for cause-specific mortality by cognitive
     impairment status
     Adjusted Hazard Ratios for mortality due to all-cause demonstrated 
that ‘bathing’ task was increased significantly across growing severity of 
cognitive impairment. Except ‘bathing’, other tasks were increased in 
moderate to severe cognitive function status (Table 13).
     Adjusted Hazard Ratios for mortality due to vascular disease revealed 
that ‘bathing’, ‘dressing’ and ‘toileting’ were significantly increased in a 
robust dose-response relationship to the cognitive impairment status. On 
the other hand ‘moving in bed’, and ‘moving around the house’ were 
related to severe cognitive impairment status (Table 14).
     Adjusted Hazard Ratios for mortality due to senile presented 
significant relationship between task-specific ADLs and moderate cognitive 
impairment status, while ‘toileting’, ‘moving in bed’, ‘moving around the 
house’, and ‘continence’ tasks were increased in a robust dose-response 
relationship (Table 15).
     In the cancer mortality, only ‘toileting’ task was higher in risk 
(HR=3.02, 1.03-8.84) by the moderate cognitive impairment status 
(Appendix table 11).
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Table 13. Task-specific ADL for all-cause mortality by cognitive impairment status
Task-specific ADL ADL status
Cognitive impairment
No or Mild*　
(N=686)
Moderate* 
(N=441)
Severe*
(N=150)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
All-cause mortality　              event 404 295 119
  Bathing Independence 1.00 1.00 1.00
Dependence 1.53(1.19-1.99) 0.0012 1.71(1.31-2.24) <.0001 1.58(1.01-2.48) 0.0476
  Dressing Independence 1.00 1.00 1.00
Dependence 1.23(0.88-1.71) 0.2230 2.14(1.57-2.93) <.0001 1.63(1.01-2.62) 0.0451
  Toileting Independence 1.00 1.00 1.00
Dependence 0.99(0.68-1.45) 0.9616 1.87(1.33-2.63) 0.0003 1.57(0.97-2.56) 0.0688
  Moving in Bed Independence 1.00 1.00 1.00
Dependence 1.00(0.80-1.26) 0.9937 1.66(1.27-2.17) 0.0002 2.49(1.57-3.95) 0.0001
  Moving around the house Independence 1.00 1.00 1.00
Dependence 1.07(0.86-1.33) 0.5639 1.70(1.31-2.20) <.0001 2.07(1.32-3.25) 0.0016
  Eating Independence 1.00 1.00 1.00
Dependence 0.97(0.57-1.65) 0.9066 2.26(1.46--3.48) 0.0002 1.29(0.70-2.39) 0.4191
  Continence Independence 1.00 1.00 1.00
Dependence 0.53(0.27-1.05) 0.0701 2.29(1.53-3.43) <.0001 1.77(1.01-3.13) 0.0481
ADL, Activity of daily living; HR (95% CI), Hazard Ratios 95% confidence intervals 
*Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
             BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
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Table 14. Task-specific ADL for vascular disease mortality by cognitive impairment status 
Task-specific ADL ADL levels
Cognitive impairment
No or Mild*　
(N=686)
Moderate* 
(N=441)
Severe*
(N=150)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
Vascular disease　mortality event 82 72 26
  Bathing Independence 1.00 1.00 1.00
Dependence 1.86(1.10-3.16) 0.0215 2.15(1.27-3.64) 0.0043 2.76(1.05-7.26) 0.0390
  Dressing Independence 1.00 1.00 1.00
Dependence 1.73(0.92-3.25) 0.0904 2.59(1.41-4.77) 0.0022 3.81(1.44-10.04) 0.0069
  Toileting Independence 1.00 1.00 1.00
Dependence 1.34(0.62-2.88) 0.4577 2.34(1.20-4.55) 0.0124 2.90(1.09-7.72) 0.0335
  Moving in Bed Independence 1.00 1.00 1.00
Dependence 0.84(0.50-1.40) 0.5015 1.48(0.86-2.55) 0.1547 4.83(1.73-13.51) 0.0027
  Moving around the house Independence 1.00 1.00 1.00
Dependence 1.10(0.68-1.79) 0.6936 1.59(0.95-2.67) 0.0799 3.85(1.36-10.90) 0.0111
  Eating Independence 1.00 1.00 1.00
Dependence 2.31(0.99-5.39) 0.0530 2.17(0.90-5.28) 0.0861 1.67(0.51-5.49) 0.4017
  Continence Independence 1.00 1.00 1.00
Dependence 0.86(0.26-2.85) 0.7997 2.15(0.94-4.92) 0.0700 2.60(0.94-7.20) 0.0651
ADL, Activity of daily living; HR (95% CI), Hazard Ratios 95% confidence intervals 
*Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
             BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
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Table 15. Task-specific ADL for senile mortality by cognitive impairment status 
Task-specific ADL ADL levels
Cognitive impairment
No or Mild*　
(N=686)
Moderate* 
(N=441)
Severe*
(N=150)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
Senile mortality                   event 129 117 50
  Bathing Independence 1.00 1.00 1.00
Dependence 1.72(1.11-2.67) 0.0158 1.75(1.14-2.68) 0.0112 1.26(0.61-2.60) 0.5284
  Dressing Independence 1.00 1.00 1.00
Dependence 1.47(0.85-2.56) 0.1692 1.78(1.06-2.99) 0.0302 1.23(0.55-2.73) 0.6144
  Toileting Independence 1.00 1.00 1.00
Dependence 1.22(0.66-2.23) 0.5291 1.57(0.89-2.76) 0.1193 0.97(0.41-2.28) 0.9352
  Moving in Bed Independence 1.00 1.00 1.00
Dependence 0.89(0.60-1.33) 0.5641 1.82(1.19-2.80) 0.0063 2.54(1.24-5.18) 0.0108
  Moving around the house Independence 1.00 1.00 1.00
Dependence 0.97(0.66-1.43) 0.8730 1.70(1.11-2.60) 0.0141 2.20(1.11-4.36) 0.0235
  Eating Independence 1.00 1.00 1.00
Dependence 0.61(0.20-1.85) 0.3770 2.45(1.24-4.86) 0.0104 1.64(0.65-4.10) 0.2944
  Continence Independence 1.00 1.00 1.00
Dependence 0.33(0.08-1.41) 0.1348 2.08(1.09-3.97) 0.0265 2.85(1.18-6.89) 0.0203
ADL, Activity of daily living; HR (95% CI), Hazard Ratios 95% confidence intervals 
*Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
             BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
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  E. Combined effect of cognitive impairment and ADL              
       disability 
  1. Combined effects for cause-specific mortality 
     The combined bar chart, Figure 2 (all-cause mortality), Figure 3 
(vascular disease mortality), and Figure 4 (senile mortality) demonstrated 
the relationship between ADL disability level and cognitive impairment 
status after the adjustment of all the controlling confounders; age, gender, 
education, occupation, marriage, smoker (former, current), drinker (former, 
current), BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and 
hypertension. In place of separate analyses of cognitive impairment or 
ADL disability with mortality, hazard ratio was higher when cognitive 
impairment and ADL disability were combined. Both moderate and severe 
in cognitive impairment and dependence in ADL were associated with 
higher mortality.
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   Figure 2. Combined effect of cognitive impairment status and ADL level for     
             All-cause mortality.
   Figure 3. Combined effect of cognitive impairment status and ADL level for           
               Vascular disease mortality.
   Figure 4. Combined effect of cognitive impairment status and ADL level for           
               Senile mortality. 
            *Adjusted for age, gender, education, occupation, marriage, smoker (former,  
            current), drinker (former, current), BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5),   
            self-rated health, and hypertension
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  2. Calculating measures of biological interaction 
     
    We calculated the relative excess risk due to biological interaction by 
computerizing on the excel sheet after obtaining the adequate estimates 
from SAS program. The Relative Excess Risk due to biological Interaction 
(RERI) of vascular disease mortality was increased when cognitive 
impairment and ADL disability were combined. The effects indicated 
all-cause (HR=0.96, p=0.0031), vascular disease (HR=1.63, p=0.0545), and 
senility (HR=0.57, p=0.2703) in Figure 2, 3, and 4 adjusted for age, 
gender, education, occupation, marriage, smoker (former, current), drinker 
(former, current), BMI (<18.5; 18.5-20.9; 25-27.4; and ≥27.5), self-rated 
health, and hypertension.
     The formula as below; 
           (Andersson et al., 2005)
    Synergy Index (S) due to biological interaction of all-cause, vascular 
disease, senile mortality was increased when cognitive impairment and 
ADL disability were combined. The effects indicated all-cause (HR=2.72), 
vascular disease (HR=3.40), and senility (HR=1.58) in Figure 2, 3, and 4. 
     The formula as below; 
    
 
  (Andersson et al., 2005)
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  3. Biological interaction for cause-specific mortality 
     The following figures showed the interaction of cognitive impairment and 
ADL for each ADL task (7 ADL tasks). ADL was divided by bivariables 
(independence, dependence). Cognitive impairment status was divided by three 
groups within of MMSE-K score (no, or mild = more higher than 19, moderate = 
14-18, severe = less than 13) adjusted for age, gender, education, occupation, 
marriage, smoker (former, current), drinker (former, current), BMI (<18.5; 
18.5-20.9; 25-27.4; and ≥27.5), self-rated health, and hypertension.
     Most of figures were observed as a higher positive interaction between 
cognitive impairment and  ADL disability. Figure 5-1 and Figure 5-2 showed 
mortality due to all-cause; Figure 6-1 and Figure 6-2 showed mortality due to 
vascular disease; Figure 7-1 and Figure 7-2 showed mortality due to senile. Bar 
chart for cause-specific mortality presented different patterns. Cognitive function 
and ADL disability affected the mortality of the older adults.
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Figure 5-1. Combined effect of cognitive impairment status and ADL level for All-cause mortality. 
            Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
            BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
      a. All-cause mortality
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Figure 5-2. Combined effect of cognitive impairment status and ADL level for All-cause mortality. 
            Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
            BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
- 43 -
Figure 6-1. Combined effect of cognitive impairment status and ADL level for Vascular disease mortality. 
            Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
            BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
      b. Vascular disease mortality
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Figure 6-2. Combined effect of cognitive impairment status and ADL level for Vascular disease mortality. 
            Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
            BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
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Figure 7-1. Combined effect of cognitive impairment status and ADL level for Senile mortality. 
            Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
            BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
       c. Senile mortality
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Figure 7-2. Combined effect of cognitive impairment status and ADL level for Senile mortality. 
            Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), 
            BMI (<18.5; 18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
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V. DISCUSSION
     In this study, we examined that cognitive impairment was significantly 
associated with increased mortality due to all-cause, vascular disease, and 
senility adjusted with confounding variables (age, gender, education, 
occupation, marriage, smoking status, drinking status, BMI categories, 
self-rated health, hypertension). And mild cognitive impairment (MCI) was 
associated with mortality due to all-cause and senility compared to no 
cognitive impairment. Some of domain-specific cognitive impairments were 
associated with increased mortality due to all-cause, vascular disease, and 
senility. Activities of daily living (ADL) were strongly related with increased 
mortality due to all-cause, vascular disease, and senility compared to ADL 
independency. Task- specific ADL had a striking effect on mortality due to 
all-cause, vascular, and senility. However, mortality due to cancer did not 
increase for cognitive domains and ADL tasks. Stratification by cognitive 
impairment gave a trend toward higher HR for mortality due to all-cause, 
vascular disease, and senility. Domain-specific cognitive function and 
task-specific ADL showed different results for cause-specific mortality.
     Our findings are similar to the results of previous studies indicating 
an association between cognitive impairment and mortality due to all-cause 
(Schupf et al., 2005; Santabárbara et al., 2014), vascular disease (Suh et 
al., 2005; Suh. 2006; Clarke et al., 2011; O’Donnell et al., 2012), and 
senility (NHS, 2010). However, no association is found between cognitive 
impairment and cancer mortality (Anstey et al., 2006). Cognitive impairment 
has shown remarkable effects on cause-specific mortality. In the 
meta-analysis after controlling the socio-demographic characteristics, 
comorbidity, and functional limitations, moderate and severe cognitive 
- 48 -
impairment have known to be associated with higher mortality (Guehne et 
al., 2007).
     Compared to ADL independency, ADL is closely related with 
increased mortality due to all-cause (Stineman et al., 2012), vascular 
disease (Suh 2006) and senility (Solfrizzi et al., 2012). However, no 
statistically significant difference is found between cancer mortality and 
ADL disability (Raji et al., 2004).
     Combined effect measured by ADL disability and cognitive impairment 
showed higher risks for coexisting variables than for either cognitive 
impairment or ADL disability. We calculated the relative excess risk due to 
interaction by computerizing the account. When cognitive impairment and 
ADL disability were combined, the vascular disease mortality was 
increased with the relative excess risk due to interaction (RERI). The 
mortality due to all-cause, vascular disease, and senility was increased by 
the Synergy Index due to Interaction.
     Our study suggests that older adults with coexisting ADL and 
cognitive impairment are more likely to have shorter lifespan than those 
without coexisting impairment.
All-cause mortality
     We reported the association between cognitive impairment and 
mortality due to all-cause showed in our study. The mortality risk 
increased equivalently to the status (HR=1.21, 1.04-1.40 in moderate; 
HR=1.61, 1.31-1.98 in severe) with potential confounding variables in our 
study. And there was a dose-response relationship between cognitive 
impairment and all-cause mortality. From a 17-year follow-up in a 
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community based Spanish study, cognitive impairment is associated with 
mortality due to all-cause adjusted for sociodemographical variables and 
medical variables (HR=1.29, 1.03-1.61 in moderate; HR=2.08, 1.42-3.04 in 
severe). The EPIC-Greece cohort study evaluated an increased risk that 
appears in all-cause mortality (MMSE score 10-20) (Katsoulis et al., 2014). 
Ramos et al. indicated that a MMSE score of ≤18 has mortality risk 
almost two times higher than those with a higher MMSE score (Ramos et 
al., 2001). In addition, other studies reported similarity to our results for 
the associations between cognitive impairment and mortality due to 
all-cause (Schupf et al., 2005; Santabárbara et al., 2014).
     After controlling for covariates, some of domain-specific cognitive 
impairments were associated with increased mortality due to all-cause in 
this study. Especially ‘orientation to time’, ‘orientation to place’, ‘recall’, 
‘three-stage command’, ‘copying’, ‘comprehension’ ‘registration’, and 
‘attention and calculation’ domains were associated with increased risk in 
all-cause mortality. Like this study, Park et al. reported ‘orientation to time’ 
and ‘attention and calculation’ domains are independently associated with 
increased risk of mortality (Park et al., 2012). Iwasa et al. reported that 
mortality due to all-cause increases with cognitive impairment adjusted for 
‘orientation to time’, ‘orientation to place’, ‘attention and calculation’, and 
‘recall’ are significantly associated with mortality (Iwasa et al., 2013). Also 
Takata et al. reported that ‘orientation to time’, ‘orientation to place’, 
‘recall’, ‘naming and repetition’, and ‘listening and obeying’ are associated 
with all-cause mortality (Takata et al., 2014).
     Moderate (MMSE score 14-18) and severe (MMSE score 0-13) 
impairment in cognitive impairment are also independent predictors of 
all-cause mortality (Ramos et al., 2001; Katsoulis et al., 2014). These 
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results are similar to our study. The results of earlier studies, which 
reported that cognitive domains are associated with all-cause mortality, 
correspond with the results of the present study (Park et al., 2012; Iwasa 
et al., 2013; Takata et al., 2014).
     The mortality risk is increased more in ADL dependency than in ADL 
independency (Stineman et al., 2012). A longitudinal study from Canada, 
ADL disability is statistically significant to mortality due to all-cause after 
adjusting for age, gender, education, and self-rated health (St John et al., 
2002). After the trans-catheter aortic valve implantation cohort study, ADL 
disability is related with increased mortality due to all-cause (HR=3.36, 
1.29-810.23) (Stortecky et al., 2012). The mortality due to all-cause was 
increased with ADL dependency in our study. Our results coincides with 
those of previous studies.
     In this study, all task-specific ADLs had striking effects on mortality 
due to all-cause in every model. A study from Korea indicates that ADL of 
‘toileting’, ‘eating’, ‘dressing’, ‘bladder and bowel control’, ‘mobility’ and 
‘bathing’ are significant predictors of all-cause mortality (Suh. 2006). 
Moreover, according to a 2-year follow-up study in Brazil, ‘continuance’ 
task is associated with all-cause mortality (Ramos et al., 2001). An 1-year 
prospective study, Nakazawa et al. reported that ADL measured by the 
Barthel Index (basic activities of daily living) is associated with increased 
risk of ‘feeding’, ‘transferring’, ‘toileting’, ‘bathing’, ‘dressing’, and ‘continent’ 
tasks in nursing homes (Nakazawa et al., 2012). In the community-dwelling 
study from Japan, ‘eating’, ‘dressing’, ‘bathing’, ‘toileting’, and ‘moving 
around the house’ tasks measured by the HDS (Hasegawa Index) are 
associated minimal dependency (Dodge et al., 2005). ADL dependency 
has been presented to be a predictor of mortality in older adults (Ramos 
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et al., 2001; St John et al., 2002; Stineman et al., 2012). This association 
is proved in our study; ADL dependency has been investigated to be a 
predictor of mortality in older adults. This study demonstrated that most of 
ADL tasks exist with the risk for all-cause mortality (Dodge et al., 2005 
and Nakazawa et al., 2012).
Vascular disease mortality
     Our study showed that mortality due to vascular disease was 
associated with severe cognitive impairment status after age and gender 
were adjusted. One of the short follow-up longitudinal cohort studies 
(Nguyen et al., 2003) presented that cognitive impairment in older adults is 
associated with mortality due to stroke after controlling the 
socio-demographic characteristics. The relationship between MMSE score 
and mortality due to vascular disease is strongly associated with increased 
risk as reported by the study conducted in Canada. Compared to the 
reference (MMSE score=30), mortality due to stroke, unstable or new 
angina, prior stroke or myocardial infarction, and congestive heart failure 
are associated with MMSE score <24 (HR=1.44, HR=1.12, HR=1.38, 
HR=1.43 p<0.0001, respectively) (O'Donnell et al., 2012). The 
EPIC-Greece cohort study reported that CVD mortality increases the 
hazard ratio in MMSE score 10-20 (Katsoulis et al., 2014). Wu et al. also 
reported cognitive impairment measured by the SPMSQ (10-items cognitive 
index, short portable mental status questionnaire) is associated with an 
increased risk of mortality due to circulatory disease (Wu et al., 2014). 
Paddick et al. found that dementia and even mild cognate impairment 
(MCI) are associated with excess risk mortality (Paddick et al., 2015). 
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However, a study conducted in Italy indicated that mortality due to 
ischemic stroke has no association with cognitive impairment (Altieri et al., 
2002). Cano et al. reported stroke and heart attack are not associated 
with neither cognitive impairment nor mortality (Cano et al., 2012).
      A study conducted in Canada by O’Donnell et al. reported that 
‘orientation to place’, ‘orientation to time’, ‘attention and calculation’, ‘recall’, 
and ‘copying’ are increased categorized as domains of CV mortality; 
‘orientation to place’, ‘attention and calculation’, and ‘recall’ are increased 
as domains of stroke; ‘orientation to place’, ‘attention and calculation’, and 
‘writing’ are increased as domains of congestive heart failure. These 
domains predicted the mortality due to vascular events (O’Donnell et al., 
2012). Our results were consistent with ‘orientation to place’ and 
‘three-stage command’ for the mortality due to vascular disease.
     Although results from early studies have various associations between 
cognitive impairment and vascular disease mortality (Altieri et al., 2002; 
O’Donnell et al., 2012; Cano et al., 2012; Katsoulis et al., 2014; Wu et 
al., 2014; Paddick et al., 2015), our study may provide clear answers that 
severe cognitive impairment increased the hazard ratio with long follow-up 
cohort study. ‘Orientation to place’ and ‘three-stage command domains 
independently increased the hazard ratios in our participants. 
     We found an increase in mortality due to vascular disease (HR=1.91, 
144-2.53) after adjusting for confounding variables with dependency in 
ADL. A study from Korea indicates that cerebrovascular disease has 
appeared to be a predictor of general mortality in older ages (Suh. 2006). 
Takata et al. found that mortality is increased with the patients who have 
cardiovascular disease patients aged 80 years or older, ADL disability is 
associated with increased risks of ADL-2 (almost-independence group, 
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HR=1.86, 1.05-3.15) and ADL-3 (dependent group, HR=0.97, 0.23-4.03) 
(Takata et al., 2013). Stineman et al. suggested that stroke and coronary 
artery disease are associated with mortality according to ADL stage from 
the big longitudinal study (Stineman et al., 2012). As cardiovascular and 
cerebral events occur after trans-catheter aortic valve implantation in 
1-year prospective cohort study, ADL disability is related to increased 
mortality for patients aged 70 years and older (HR=3.63, p<0.01) 
(Stortecky et al., 2012). ADL dependency has been presented to be a 
predictor of vascular disease mortality in older adults (Dodge et al., 2005; 
Suh. 2006; Stortecky et al., 2012; Stineman et al., 2012; Takata et al., 
2013). This association is corroborated by our study.
     Stroke has contributed to functional disability (Hayakawa et al., 2000; 
Lee et al., 2002; Chang et al., 2015). It has higher and the most 
persistent impact on every ADL task. Dodge et al. reported that stroke is 
associated with all of ADL tasks (Dodge et al., 2005). We found that all 
task-specific ADLs, ‘bathing’, ‘dressing’, ‘toileting’, ‘moving in bed’, ‘moving 
around the house’, ‘eating’, ‘continence’ and mortality due to vascular 
disease had a significant association. Other previous studies presented 
that ‘dressing’ task is a major domain affected by stroke (Blankevoort et 
al., 2010). ‘Fecal and urinary incontinence’ and stroke history are 
influenced by ADL disability (Ha et al., 2014). Also ‘eating’ task in stroke 
has the highest impact disability (Greiner et al., 1996; Dodge et al, 2005). 
This study demonstrated that most of ADL tasks exist with the mortality 
risk for vascular disease.
Senile mortality
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     Our result showed that mortality due to senility was associated with 
the increased risk of developing MCI and moderate to severe cognitive 
impairment in community-dwelling older adults. In Taiwanese study, they 
confirmed a significant effect between frail status and cognitive impairment 
without dementia. Inferior cognitive impairment shows at the early stage of 
frailty (Wu et al., 2015). According to the British report, death due to 
dementia or senility appears on the top ten causes of deaths (The 
National End of Life Care Intelligence Network, 2010). Cano et al. reported 
that both senility and cognitive impairment increased mortality in older 
Mexican American (Cano et al., 2012). More over the Italian study, frail 
demented patients are higher risk of mortality (Solfrizzi et al., 2012). Our 
results have the same result as the previous study (HR=1.45, 1.63-3.31 in 
mild; HR=1.61, 1.63-3.31 in moderate; HR=2.32, 1.63-3.31 in severe) with 
senile mortality adjusted for age, gender, education, occupation, marriage, 
smoking status, drinking status, BMI, self-rated health, and hypertension. In 
this study, domain-specific cognitive impairments for senile mortality were 
significantly associated with most of the domains, ‘orientation to time’, 
‘registration’, ‘attention and calculation’, ‘recall’, ‘three-stage command’, 
‘comprehension’ and ‘copying’. Especially, 'copying' (HR=1.90; 1.41-2.55) 
domain had higher risk score than any other domains.
     Senility was associated with cognitive impairment even mild cognitive 
impairment and ADL disability in this study. Boyle et al. discovered that 
physical frailty is associated with an increased risk of developing MCI in 
the community-dwelling older adults. Frailty and cognitive impairment are 
separate clinical syndromes that share some features. They suggested that 
physical frailty and cognitive impairment share a common contributory 
pathogenesis (Boyle et al., 2007).
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     In this study, we indicated the analysis of mortality according to R54 
(senility) in ICD-10 code which is mentioned on death certificates; 
however, support of our result for mortality due to R54 in ICD-10 was 
insufficient because other previous studies did not focused on R54, and 
they used frailty index with different definition. Senility/frailty brings a 
biological and physiological change with aging (Ma et al., 2009; Fried et 
al., 2001). Senility has no clear definition, so geriatricians has different 
views on operational definitions. Fried et al. defined potential definitions of 
senility as a synonym for disability, comorbidity, or advanced old age 
(Fried et al., 2001).
     We found that mortality due to senility showed an association with 
ADL dependency. Fauth et al. reported that ADL carried an 83% higher 
risk of developing incident dementia compared to those without baseline 
ADL disability (Fauth et al., 2012). Senility is associated with increased 
risk of disability and comorbidity (Al Snih et al., 2009; Wong et al., 2010). 
In the Cardiovascular Health Study, it shows that frail participants are at 
high risk for reduced ADL (Fried et al., 2001). Snih et al. found pre-frail 
(HR=1.26; 1.05-1.52) and frail (HR=2.03; 1.40–2.94) in older Mexican 
Americans are associated with an increased risk of ADL disability over 
10-year follow up (Snih et al., 2009). Another report, IADL impairment are 
more likely to be converted to dementia compared to those with MCI 
without reported IADL problems. Thus, it is clinically important to detect 
changes in ADL at an early stage (Jefferson et al., 2008; Goldberg et al., 
2010; Ha et al., 2014). We indicated that the mortality due to senility was 
significantly increased in the risk for ‘bathing’, ‘dressing’, ‘toileting’, ‘moving 
around the house’, and ‘eating’. Most tasks in ADL were not confirmed 
with other researches, because since they focused on different definitions. 
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A decline at ADL in particular accelerates in moderate dementia. 
Therefore, it is important to improve or stabilize the ability to perform ADL 
(Feldman et al., 2006; Ha et al., 2014).
Cancer mortality
     In this study, mortality due to cancer was not associated with 
cognitive impairment. Cancer mortality with cognitive impairment has rarely 
been reported. In the NEDICES study (Benito-León et al., 2014), faster 
cognitive decline without dementia measured by the 37-MMSE version is 
associated with the decreased risk of cancer mortality based on 
community-dwelling participants (unadjusted HR=0.75, 0.57-0.99). 
Otherwise, in the US study for Mexican Americans (Nguyen et al., 2003), 
cancer mortality is associated with decline cognitive function. Also the 
EPIC-Greece cohort study shows increasing risk in the relationship 
between cancer and low MMSE score (10-20) (Katsoulis et al., 2014). The 
meta-analysis cognitive function does not predict cancer mortality (Anstey 
et al., 2006). Our results, no statistically significant difference was found 
between cause-specific mortality and ADL disability.
Combined Effects
     We stratified cognitive impairment (no or mild, moderate, severe) and 
ADL disability (independence, partial dependence, dependence) by mortality 
due to all-cause, vascular disease, and senility. We found a strong 
association with mortality in cognitive impairment as well as with ADL 
disability due to all-cause, vascular disease, and senility. Combined effect 
- 57 -
measured by ADL disability and cognitive impairment showed higher risks 
for coexisting variables than for cognitive impairment or ADL disability 
alone.
     Mortality risk showed a greater likelihood when cognitive impairment 
and ADL disability were combined than when cognitive impairment or ADL 
disability was individually investigated. The highest impact on ‘bathing’ ADL 
disability by no or mild cognitive impairment led to increased hazard ratios 
in mortality due to all-cause (HR=1.53, p=0.0012), vascular disease 
(HR=1.86, p=0.0215), senility (HR=1.72, p=0.0158) in this study. The result 
shows that mortality was increased with ADL disability in ‘bathing’ task 
even when cognitive impairment was absent or mild.
     Mortality is lower when, 1) there is no ADL disability even in the 
presence of moderate cognitive impairment, or 2) cognitive impairment is 
below mild even through ADL indicates partial dependency. Therefore, 
mortality risk could be lowered when one of cognitive or ADL function 
functional capacity is maintained.
     The Relative Excess Risk due to biological Interaction (RERI) of 
vascular disease mortality was increased when cognitive impairment and 
ADL disability were combined. The effects indicated all-cause (HR=0.96, 
p=0.0031), vascular disease (HR=1.63, p=0.0545), and senility (HR=0.57, 
p=0.2703). Synergy Index (S) due to biological interaction (HR=2.72), 
vascular disease (HR=3.40), and senility (HR=1.58) were increased when 
cognitive impairment and ADL disability were combined. Functional capacity 
was a key predictor for surviving of older adults who have cognitive 
function and physical ability.
     Our study suggests that older adults with coexisting ADL and 
cognitive impairment are more likely to have shorter lifespan than those 
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without coexisting impairments.
     Some potential limitations. First, we were unable to measure 
cognitive decline because MMSE-K scores were measured only at the 
baseline of the study. Second, this study is its limited reliance on 
self-reporting of ADL and MMSE score. Third, It could not be able to 
confirmed the diagnose Alzheimer disease or dementia through imaging 
techniques before and after. Forth, It could not be ruled out of death due 
to senility with dementia or Alzheimer disease without doctor's diagnosis.   
     Our study has remarkable strengths. The prospective study design 
minimized recall bias. The big sample size, and long period (14.5-yrs 
follow-up) relatively long compared with other studies.
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VI. CONCLUSION
     A simple screen of cognitive function and ADL provides important 
prognostic information of community-dwelling older adults. The cognitive 
impairment and ADL disability are important factors to increase the risk of 
mortality due to all-cause, vascular disease, and senility, but  cancer didn’t 
suggest concrete. Domain-specific cognitive function and task-specific ADL 
predicted mortality risk. Previous studies and our results indicated that the 
risk with evidence should consider the functional capacity for older adults. 
Thus, evidence based risk can be used to forecast service needs and 
develop intervention programs for older adults.
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Appendix table 1. Distribution of domain-specific cognitive impairment at baseline by cognitive impairment status in the Kangwha cohort    
                 study during 1994-2008
Domain-specific Cognitive impairment Total (N=2,501)
None 
(n=1,910)
Mild (n=441)
Mod to Severe 
(n=150)
p-value
Time Orientation No or mild 1,926(77.0) 1,733(90.7) 160(36.3) 33(22.0) <0.0001
Moderate & severe 575(23.0) 177( 9.3) 281(63.7) 117(78.0)
Place Orientation No or mild 2,151(86.0) 1,822(95.4) 282(64.0) 47(31.3) <0.0001
Moderate & severe 350(14.0) 88( 4.6) 159(36.0) 103(68.7)
Registration No or mild 2,214(88.5) 1,835(96.1) 339(76.9) 40(26.7) <0.0001
  Moderate & severe 287(11.5) 75( 3.9) 102(23.1) 110(73.3)
Attention and Calculation No or mild 1,142(45.7) 1,089(57.0) 48(10.9) 5( 3.3) <0.0001
Moderate & severe 1,359(54.3) 821(43.0) 393(89.1) 145(96.7)
Recall No or mild 1,227(49.1) 1,118(58.5) 101(22.9) 8( 5.3) <0.0001
Moderate & severe 1,274(50.9) 792(41.5) 340(77.1) 142(94.7)
Naming and Repetition No or mild 2,398(95.9) 1,871(98.0) 417(45.6) 110(73.3) <0.0001
Moderate & severe 103(4.1) 39( 2.0) 24( 5.4) 42(26.7)
Three-stage Command No or mild 2,313(92.5) 1,850(96.9) 380(86.2) 83(55.3) <0.0001
Moderate & severe 188(7.5) 60( 3.1) 61(13.8) 72(44.7)
Copying No or mild 738(29.5) 693(36.3) 35( 8.0) 10( 6.7) <0.0001
Moderate & severe 1,763(70.5) 1,217(63.7) 406(92.0) 140(93.3)
Comprehension No or mild 1,890(75.6) 1,635(85.6) 219(49.7) 36(24.0) <0.0001
Moderate & severe 611(24.4) 275(14.4) 222(50.3) 114(76.0)
Values are presented as number(%); MMSE-K, Korea Mini-Mental State formeramination
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Appendix table 2. Distribution of domain-specific cognitive impairment at baseline by ADL levels in Kangwha Cohort Study
Domain-specific Cognitive impairment 
total 
(n=2,501)
Activity of Daily Living Level
p-valueIndependence
(n=1,737) 
Partial dependence
(n=432)
Dependence
(n=332) 
Orientation to time No or mild 1,926(77.01) 1,367(78.70) 338(78.24) 221(66.57) <0.0001
Moderate & severe 575(22.99) 370(21.30) 94(21.76) 112(33.43)
Orientation to place No or mild 2,151(86.01) 1,513(87.10) 377(87.27) 261(78.61) 0.0002
Moderate & severe 350(13.99) 224(12.90) 55(12.73) 71(21.39)
Registration No or mild 2,214(88.52) 1,552(89.35) 390(90.28) 272(81.93) 0.0002
Moderate & severe 287(11.48) 185(10.65) 42( 9.70) 60(18.07)
Attention & Calculation No or mild 1,142(45.66) 843(48.53) 189(43.75) 110(33.13) <0.0001
Moderate & severe 1,359(54.34) 894(51.47) 243(56.25) 222(66.97)
Recall No or mild 1,227(49.06) 924(53.20) 192(44.44) 111(33.43) <0.0001
Moderate & severe 1,274(50.94) 813(46.80) 240(55.56) 221(66.57)
Naming & Repetition No or mild 2,398(95.88) 1,667(95.97) 419(96.99) 312(93.98) 0.1090
Moderate & severe 103( 4.12) 70( 4,03) 13( 3.01) 20( 6.02)
Three-stage Command No or mild 2,313(92.48) 1,626(93.61) 400(92.59) 287(86.45) <0.0001
Moderate & severe 188( 7.52) 111( 6.39) 32( 7.41) 45(13.55)
Copying No or mild 738(29.51) 564(32.47) 122(28.24) 52(15.66) <0.0001
Moderate & severe 1,763(70.49) 1,173(67.53) 310(71.76) 280(84.34)
Comprehension No or mild 1,890(75.57) 1,371(78.93) 306(70.83) 213(64.16) <0.0001
Moderate & severe 611(24.43) 366(21.07) 128(29.17) 119(35.84)
HR (95% CI), Hazard Ratios 95% confidence intervals; 
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Appendix table 3. Distribution of task-specific ADL level at baseline by ADL level in Kangwha Cohort Study
Task-specific ADL
Activity of Daily Living Level
Total (N=2,501)
Independence 
(N=1,737)
Partial dependence 
(N=432)
Dependence  
(N=332)
p-value
Bathing <0.0001
  Independence 2,131(85.2) 1,737(100.0) 347(80.3) 47(14.2)
  Dependence 370(14.8) 0( 0.0) 85(16.7) 285(85.8)
Dressing <0.0001
  Independence 2,279(91.1) 1,737(100.0) 427(98.8) 115(34.6)
  Dependence 222( 8.9) 0( 0.0) 5( 1.2) 217(65.4)
Toileting <0.0001
  Independence 2,327(93.0) 1,737(100.0) 431(99.8) 159(47.9)
  Dependence 174( 7.0) 0( 0.0) 45( 0.2) 173(52.1)
Moving in Bed 0.001
  Independence 1,955(78.2) 1,737(100.0) 182(42.1) 36(10.8)
  Dependence 546(21.8) 0( 0.0) 250(57.9) 296(89.2)
Moving around the house <0.0001
  Independence 1,909(76.3) 1,737(100.0) 148(34.3) 24( 7.2)
  Dependence 592(23.7) 0( 0.0) 284(65.7) 308(92.8)
Eating <0.0001
  Independence 2,413(96.5) 1,737(100.0) 432(100.0) 244(73.5)
  Dependence 89( 3.5) 0( 0.0) 0( 0.0) 88(26.5)
Continence <0.0001
  Independence 2,409(96.3) 1,737(100.0) 666(90.7) 280(84.8)
  Dependence 92( 3.7) 0( 0.0) 40( 9.3) 52(15.7)
Values denote mean±SD or numbers with percentages (%) in parentheses; ADL, Activity of Daily Living; 
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Appendix table 4. Hazard ratios (95% CI) for cancer mortality with domain-specific cognitive impairment 
Domain-specific Cognitive impairment 
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Cancer mortality (n=232)
  Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.13(0.80-1.59) 0.5016 1.11(0.78-1.58) 0.5465 1.11(0.78-1.57) 0.5771
  Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 1.02(0.65-1.62) 0.9209 0.99(0.62-1.56) 0.9504 0.97(0.61-1.54) 0.9089
  Registration No or mild 1.00 1.00 1.00
Moderate & severe 1.08(0.69-1.70) 0.7402 1.06(0.67-1.67) 0.8182 1.05(0.66-1.66) 0.8455
  Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 0.96(0.73-1.25) 0.7484 0.98(0.75-1.29) 0.8979 0.98(0.74-1.29) 0.8741
  Recall No or mild 1.00 1.00 1.00
Moderate & severe 0.81(0.62-1.05) 0.1109 0.81(0.62-1.06) 0.1177 0.81(0.62-1.06) 0.1189
  Naming & Repetition No or mild 1.00 1.00 1.00
Moderate & severe 1.09(0.59-1.99) 0.7882 1.05(0.57-1.95) 0.8747 1.05(0.57-1.95) 0.8757
  Three-stage Command No or mild 1.00 1.00 1.00
Moderate & severe 0.55(0.27-1.12) 0.1013 0.53(0.26-1.07) 0.0746 0.52(0.26-1.06) 0.072
  Copying No or mild 1.00 1.00 1.00
Moderate & severe 1.22(0.92-1.62) 0.1708 1.21(0.90-1.63) 0.2007 1.21(0.90-1.63) 0.2128
  Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 0.96(0.68-1.37) 0.8314 0.97(0.68-1.39) 0.8804 0.98(0.68-1.39) 0.888
HR (95% CI), Hazard Ratios 95% confidence intervals
Model 1: adjusted for age and gender 
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and ADL (partial dependence, dependence)
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Appendix table 5. Hazard ratios (95% CI) for cancer mortality with task-specific ADL
Task-specific ADL
Model 1 Model 2 Model 3
HR (95% CI) p-value HR (95% CI) p-value HR (95% CI) p-value
Cancer mortality (n=232)
  Bathing Independence 1.00 1.00 1.00
Dependence 0.92(0.57-1.48) 0.728 0.92(0.57-1.50) 0.74 0.91(0.56-1.49) 0.7192
  Dressing Independence 1.00 1.00 1.00
Dependence 0.95(0.52-1.76) 0.8802 0.96(0.52-1.79) 0.9085 0.96(0.52-1.79) 0.8994
  Toileting Independence 1.00 1.00 1.00
Dependence 1.62(0.94-2.81) 0.0841 1.71(0.98-2.98) 0.0605 1.70(0.97-2.97) 0.0635
  Moving in Bed Independence 1.00 1.00 1.00
Dependence 1.17(0.84-1.63) 0.3569 1.17(0.84-1.65) 0.3535 1.18(0.84-1.66) 0.3398
  Moving around the house Independence 1.00 1.00 1.00
Dependence 1.12(0.81-1.55) 0.5123 1.10(0.79-1.53) 0.5908 1.10(0.79-1.53) 0.5769
  Eating Independence 1.00 1.00 1.00
Dependence 1.17(0.48-2.84) 0.7341 1.21(0.49-2.97) 0.679 1.20(0.49-2.96) 0.6918
  Continence Independence 1.00 1.00 1.00
Dependence 0.43(0.11-1.74) 0.2387 0.44(0.11-1.77) 0.2465 0.43(0.11-1.76) 0.2413
HR (95% CI), Hazard Ratios 95% confidence intervals 
Model 1: adjusted for age and gender
Model 2: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, and hypertension 
Model 3: adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5;
                     18.5-20.9; 25-27.4; ≥27.5), self-rated health, hypertension, and cognitive impairment (mild, moderate, severe)
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Appendix table 6. Cognitive impairment status for Cause-specific mortality by ADL level 
Cause-specific mortality/ 
          Cognitive impairment status
Independence ADL* 
(n=1,737)
Partial dependence ADL* 
(n=432)
Dependence ADL* 
(n=332)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
All-cause mortality             (event) 960 271 250
No impairment 1.00 1.00 1.00
Mild impairment 1.06(0.91-1.24) 0.4637 1.20(0.89-1.63) 0.2363 1.10(0.77-1.56) 0.6077
Moderate impairment 1.03(0.85-1.25) 0.7548 1.50(1.05-2.14) 0.0265 1.82(1.25-2.65) 0.0020
Severe impairment 1.30(0.97-1.73) 0.0773 2.55(1.51-4.30) 0.0004 2.21(1.43-3.40) 0.0003
Vascular Disease mortality      (event) 218 52 76
No impairment 1.00 1.00 1.00
Mild impairment 0.84(0.60-1.17) 0.3049 0.90(0.42-1.93) 0.7897 0.75(0.40-1.40) 0.3640
Moderate impairment 0.98(0.67-1.45) 0.9340 2.34(1.10-4.97) 0.0270 1.41(0.72-2.77) 0.3157
Severe impairment 0.85(0.42-1.70) 0.6413 4.27(1.35-13.53) 0.0136 1.97(0.93-4.16) 0.0776
Senile mortality                (event) 257 52 90
No impairment 1.00 1.00 1.00
Mild impairment 1.38(1.01-1.89) 0.0436 0.90(0.42-1.93) 0.7897 1.80(0.91-3.57) 0.0936
Moderate impairment 1.28(0.89-1.83) 0.1781 2.34(1.10-4.97) 0.0270 2.75(1.35-5.61) 0.0055
Severe impairment 1.88(1.16-3.05) 0.0110 4.27(1.35-13.53) 0.0136 3.22(1.45-7.17) 0.0042
Cancer mortality               (event) 181 31 20
No impairment 1.00 1.00 1.00 
Mild impairment 0.95(0.65-1.37) 0.7654 1.29(0.59-2.86) 0.5235 0.53(0.16-1.69) 0.2801
Moderate impairment 1.12(0.70-1.80) 0.6283 0.24(0.03-1.94) 0.1828 0.92(0.24-3.49) 0.9051
Severe impairment 1.34(0.64-2.80) 0.4321 - - 0.93(0.09-9.22) 0.9509
ADL, Activity of daily living; HR (95% CI), Hazard Ratios 95% confidence intervals; 
*Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5; 18.5-20.9;        
             25-27.4; ≥27.5), self-rated health, and hypertension, ADL (partial dependence, dependence). 
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Appendix table 7. Domain-specific cognitive impairment for all-cause mortality by ADL level
Domain-specific 
  cognitive impairment 
Cognitive status
Independence ADL* 
(n=960)
Partial dependence ADL* 
(n=271)
Dependence ADL* 
(n=250)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
All-cause mortality
Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.08(0.92-1.27) 0.3227 1.36(1.01-1.83) 0.0454 1.35(1.01-1.79) 0.0400
Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 1.04(0.85-1.26) 0.7221 1.32(0.91-1.90) 0.1400 1.79(1.32-2.43) 0.0002
Registration No or mild 1.00 1.00 1.00
Moderate & severe 1.04(0.85-1.27) 0.7009 1.29(0.87-1.90) 0.2035 1.48(1.07-2.05) 0.0188
Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 1.11(0.97-1.27) 0.1421 1.04(0.79-1.36) 0.7981 1.13(0.86-1.50) 0.3768
Recall No or mild 1.00 1.00 1.00
Moderate & severe 1.03(0.91-1.18) 0.6270 1.09(0.84-1.42) 0.4961 1.34(1.01-1.77) 0.0433
Naming & Repetition No or mild 1.00 1.00 1.00
Moderate & severe 0.99(0.72-1.35) 0.9315 1.03(0.48-2.24) 0.9347 1.76(1.05-2.95) 0.0335
Three-stage Command No or mild 1.00 1.00 1.00
Moderate & severe 0.99(0.77-1.29) 0.9648 1.36(0.90-2.06) 0.1492 1.60(1.12-2.30) 0.0103
Copying No or mild 1.00 1.00 1.00
Moderate & severe 1.15(0.99-1.35) 0.0744 1.33(0.98-1.81) 0.0676 1.36(0.91-2.03) 0.1364
Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 1.13(0.96-1.32) 0.1335 1.28(0.98-1.67) 0.0759 1.51(1.14-2.00) 0.0043
ADL, Activity of daily living; HR (95% CI), HR (95% CI), Hazard Ratios 95% confidence intervals 
*Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5; 18.5-20.9;       
              25-27.4; ≥27.5), self-rated health, and hypertension
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Appendix table 8. Domain-specific cognitive impairment for vascular disease mortality by ADL level 
Domain-specific 
  cognitive impairment Cognitive status
Independence ADL* 
(n=218)
Partial dependence ADL* 
(n=52)
Dependence ADL* 
(n=75)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
Vascular disease mortality
Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.08(0.77-1.51) 0.6660 2.42(1.26-4.67) 0.0082 1.18(0.68-2.04) 0.5534
Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 0.84(0.54-1.29) 0.4208 2.18(1.03-4.64) 0.0423 3.63(2.04-6.43) <.0001
Registration No or mild 1.00 1.00 1.00
Moderate & severe 0.80(0.50-1.27) 0.3404 3.36(1.61-7.01) 0.0012 1.50(0.81-2.77) 0.1988
Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 0.95(0.72-1.25) 0.6953 0.70(0.37-1.31) 0.2615 0.63(0.39-1.02) 0.0619
Recall No or mild 1.00 1.00 1.00
Moderate & severe 0.97(0.74-1.28) 0.8247 1.46(0.80-2.66) 0.2134 1.02(0.63-1.65) 0.9317
Naming & Repetition No or mild 1.00 - 1.00
Moderate & severe 0.75(0.35-1.61) 0.4622 - 1.27(0.49-3.31) 0.6250
Three-stage Command No or mild 1.00 1.00 1.00
Moderate & severe 0.89(0.51-1.56) 0.6824 1.58(0.62-4.07) 0.3416 2.07(1.15-3.73) 0.0154
Copying No or mild 1.00 1.00 1.00
Moderate & severe 1.07(0.77-1.48) 0.6986 0.94(0.49-1.80) 0.8444 0.89(0.46-1.72) 0.7233
Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 1.08(0.78-1.51) 0.642 1.31(0.71-2.44) 0.3904 1.62(0.96-2.74) 0.0699
ADL, Activity of daily living; HR (95% CI), HR (95% CI), Hazard Ratios 95% confidence intervals
* Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5; 18.5-20.9;      
               25-27.4; ≥27.5), self-rated health, and hypertension
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Appendix table 9. Domain-specific cognitive impairment for senile mortality by ADL level 
Domain-specific 
  cognitive impairment Cognitive status
Independence ADL* 
(n=257)
Partial dependence ADL* 
(n=81)
Dependence ADL* 
(n=90)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
Senile mortality
Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.08(0.81-1.44) 0.5997 1.24(0.73-2.10) 0.4346 1.42(0.89-2.28) 0.1452
Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 1.00(0.71-1.41) 0.9926 1.17(0.63-2.17) 0.6121 1.29(0.76-2.18) 0.3542
Registration No or mild 1.00 1.00 1.00
Moderate & severe 1.25(0.88-1.77) 0.2168 1.24(0.67-2.30) 0.5008 1.60(0.94-2.72) 0.0806
Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 1.77(1.34-2.33) <.0001 1.31(0.75-2.27) 0.3429 1.72(1.03-2.86) 0.0377
Recall No or mild 1.00 1.00 1.00
Moderate & severe 1.10(0.84-1.42) 0.4916 1.26(0.74-2.17) 0.3975 1.55(0.93-2.58) 0.0920
Naming & Repetition No or mild 1.00 1.00 1.00
Moderate & severe 0.89(0.45-1.76) 0.7358 2.90(0.85-9.87) 0.0878 2.28(0.94-5.49) 0.0670
Three-stage Command No or mild 1.00 1.00 1.00
Moderate & severe 1.32(0.85-2.03) 0.2152 1.47(0.74-2.92) 0.2714 1.80(0.94-3.47) 0.0778
Copying No or mild 1.00 1.00 1.00
Moderate & severe 1.69(1.18-2.41) 0.0043 2.31(1.14-4.68) 0.0201 2.67(1.14-6.25) 0.0238
Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 1.42(1.08-1.87) 0.0126 1.40(0.86-2.29) 0.1732 1.30(0.81-2.10) 0.2739
ADL, Activity of daily living; HR (95% CI), Hazard Ratios 95% confidence intervals; 
* Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5; 18.5-20.9;      
               25-27.4; ≥27.5), self-rated health, and hypertension
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Appendix table 10. Domain-specific cognitive impairment for cancer mortality by ADL level 
Domain-specific 
  cognitive impairment 
Cognitive status
Independence ADL* 
(n=181)
Partial dependence ADL* 
(n=31)
Dependence ADL* 
(n=20)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
Cancer mortality
Orientation to time No or mild 1.00 1.00 1.00
Moderate & severe 1.06(0.71-1.60) 0.7727 1.22(0.43-3.45) 0.7116 2.34(0.74-7.33) 0.1464
Orientation to place No or mild 1.00 1.00 1.00
Moderate & severe 0.97(0.57-1.64) 0.9036 0.55(0.07-4.37) 0.5752 1.56(0.45-5.39) 0.4846
Registration No or mild 1.00 - 1.00
Moderate & severe 1.24(0.77-2.02) 0.3795 - 0.99(0.20-4.80) 0.9867
Attention & Calculation No or mild 1.00 1.00 1.00
Moderate & severe 1.01(0.741.37) 0.9632 0.73(0.32-1.68) 0.4607 0.66(0.25-1.74) 0.3975
Recall No or mild 1.00 1.00 1.00
Moderate & severe 0.89(0.66-1.21) 0.4669 0.70(0.33-1.50) 0.3581 0.42(0.16-1.10) 0.0767
Naming & Repetition No or mild 1.00 1.00 -
Moderate & severe 1.09(0.55-2.15) 0.8023 1.67(0.36-7.75) 0.5111 -
Three-stage Command No or mild 1.00 - 1.00
Moderate & severe 0.56(0.25-1.26) 0.1618 - 1.04(0.20-5.30) 0.967
Copying No or mild 1.00 1.00 1.00
Moderate & severe 1.16(0.84-1.62) 0.3747 1.43(0.59-3.44) 0.4311 0.66(0.17-2.68) 0.5649
Comprehension No or mild 1.00 1.00 1.00
Moderate & severe 0.93(0.61-1.43) 0.7516 0.85(0.33-2.17) 0.7299 0.89(0.31-2.56) 0.8258
ADL, Activity of daily living; HR (95% CI), HR (95% CI), Hazard Ratios 95% confidence intervals
*Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5; 18.5-20.9;       
25-27.4; ≥27.5), self-rated health, and hypertension
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Appendix table 11. Task-specific ADL for senile mortality by cognitive impairment status 
Task-specific ADL ADL levels
Cognitive impairment
No or Mild*　
(N=686)
Moderate* 
(N=441)
Severe*
(N=150)
aHR (95% CI) p-value aHR (95% CI) p-value aHR (95% CI) p-value
Cancer mortality                  event 56 29 9
      Bathing Independence 1.00 1.00 1.00
Dependence 0.87(0.34-2.27) 0.779 0.60(0.17-2.09) 0.4244 4.82(0.20-114.48) 0.3302
      Dressing Independence 1.00 1.00 1.00
Dependence 0.51(0.12-2.19) 0.3614 1.25(0.36-4.37) 0.7262 7.85(0.31-201.69) 0.2137
      Toileting Independence 1.00 1.00 1.00
Dependence 1.13(0.32-3.95) 0.8521 3.02(1.03-8.84) 0.0439 12.91(0.39-431.59) 0.1532
      Moving in Bed Independence 1.00 1.00 1.00
Dependence 1.38(0.73-2.60) 0.3255 0.89(0.33-2.46) 0.8267 15.98(0.52-489.55) 0.1124
      Moving around the house Independence 1.00 1.00 1.00
Dependence 1.40(0.76-2.56) 0.2767 1.02(0.40-2.62) 0.9655 8.18(0.32-210.44) 0.2046
      Eating Independence - 1.00 1.00
Dependence - 0.89(0.11-7.11) 0.9115 43.41(0.56-3350.56) 0.0891
      Continence Independence - 1.00 -
Dependence - 0.90(0.11-7.19) 0.9229 -
ADL, Activity of daily living; HR (95% CI), HR (95% CI), HR (95% CI), Hazard Ratios 95% confidence intervals 
Adjusted for age, gender, education, occupation, marriage, smoker (former, current), drinker (former, current), BMI (<18.5; 18.5-20.9; 
25-27.4; and ≥27.5), self-rated health, and hypertension
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Abstract in Korean
노인의 인지기능장애 및 일상생활활동장애와 
사망과의 관련성 연구: 강화코호트 연구
연세대학교 대학원 보건학과
조 정 애
목적: 한국 노인들의 모든원인 사망, 혈관질환 사망, 암 사망, 노쇠로 기인한 
사망을 인지능력 수행과 일상생활활동 수행능력을 통하여 복합적으로 예측
하고 사망에 기여하는 요소들을 평가한다.
방법: 1985년 3월에 55세 이상 강화도에 거주하고 있는 6,372명을 대상으로 
코호트를 구축하였다. 추가적으로 코호트 내의 대상자에게 한국판 간이 인지
기능검사(MMSE-K)와 일상생활활동(ADL) 수행능력을 1994년 7월부터 2008
년 12월 31일까지 14년 5개월간 추적하였으며, 64세 이상 2,501명을 최종 
분석대상으로 하였다. 분석은 카이검정 및 콕스비례위험모형을 사용하였다. 
MMSE-K 점수로 인지장애 정도를 분류하였고 각 영역(9가지) 인지기능과 사
망과의 관련성 예측하였다. ADL도  점수에 따라 그룹을 분류하였으며, 직무
(7가지)와 사망과의 관련성을 확인하였다. 또한 두요소를 결합하여 효과를 
확인하였다.  
결과: 첫째, 노인들의 인지장애 및 일상생활활동장애는 암사망을 제외하고 
모든원인사망, 혈관질환사망, 노쇠사망과 높은 관련성이 있었다. 둘째, 인지
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기능의 영역별 및 일상생활활동의 직무수행별 사망과의 관련성은 다양한 연
관성을 보였으나 암사망과는 관련성이 없었다. 셋째, 인지장애와 일상생활활
동장애를 합쳐서 보았을 때 위험비는 더 높아졌고, 시너지효과가 크게 증가 
되었다. 시너지효과는 모든원인사망에서 3.72 (HR), 혈관질환사망 3.40 
(HR), 노쇠사망은 1.58 (HR)의 시너지 효과 위험비를 보였다. 
결론: 인지기능장애와 일상생활활동장애는 노인들에게 있어서 사망률을 높이
는 요인이다. 사망원인에 따라 각 영역별 인지기능장애와 직무별 일상생활활
등장애의 위험요소가 다르므로 이에 따라 노인들의 기능장애 관련요인을 고
려하면 노인들에게 적합한 보건의료 복지 서비스 개발을 하는데 있어서 전
략적인 기틀을 마련할 수 있을 것이다. 
______________________________________________________________________
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